BIOMARIN PHARMACEUTICAL INC Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-08-06: Form 10-Q; Exhibit 10.5; Description Form of Stock Options Agreement for the Amicus Therapeutics, Inc. 2025 Equity Incentive Plan..
- 2026-08-06: Form 10-Q; Exhibit 10.4; Description Form of Agreement Regarding Restricted Stock Units for the Amicus Therapeutics, Inc. 2025 Equity Incentive Plan..
- 2026-08-06: Form 10-Q; Exhibit 10.3; Description Amicus Therapeutics, Inc. 2025 Equity Incentive Plan..
- 2026-08-06: Form 10-Q; Exhibit 10.2; Description BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan, as amended..
| Filed | Form | Exhibit | Description |
|---|
| 2026-08-06 | 10-Q | 10.5 | Form of Stock Options Agreement for the Amicus Therapeutics, Inc. 2025 Equity Incentive Plan. |
|---|
| 2026-08-06 | 10-Q | 10.4 | Form of Agreement Regarding Restricted Stock Units for the Amicus Therapeutics, Inc. 2025 Equity Incentive Plan. |
|---|
| 2026-08-06 | 10-Q | 10.3 | Amicus Therapeutics, Inc. 2025 Equity Incentive Plan. |
|---|
| 2026-08-06 | 10-Q | 10.2 | BioMarin Pharmaceutical Inc. 2017 Equity Incentive Plan, as amended. |
|---|
| 2026-04-27 | 8-K | 10.1 | Credit Agreement, dated as of April 27, 2026, by and among BioMarin Pharmaceutical Inc., as the Borrower, Citibank, N.A., as administrative agent and collateral agent, and the lenders and issuing banks party thereto. |
|---|
| 2026-02-26 | 10-K | 10.18 | BioMarin Pharmaceutical Inc. Summary of Independent Director Compensation. |
|---|